Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Braz. j. med. biol. res ; 47(4): 349-354, 8/4/2014. tab
Article in English | LILACS | ID: lil-705761

ABSTRACT

The purpose of this study was to investigate the effect of supplementary vitamin D therapy in addition to amitriptyline on the frequency of migraine attacks in pediatric migraine patients. Fifty-three children 8-16 years of age and diagnosed with migraine following the International Headache Society 2005 definition, which includes childhood criteria, were enrolled. Patients were classified into four groups on the basis of their 25-hydroxyvitamin D [25(OH)D] levels. Group 1 had normal 25(OH)D levels and received amitriptyline therapy alone; group 2 had normal 25(OH)D levels and received vitamin D supplementation (400 IU/day) plus amitriptyline; group 3 had mildly deficient 25(OH)D levels and received amitriptyline plus vitamin D (800 IU/day); and group 4 had severely deficient 25(OH)D levels and was given amitriptyline plus vitamin D (5000 IU/day). All groups were monitored for 6 months, and the number of migraine attacks before and during treatment was determined. Calcium, phosphorus alkaline phosphatase, parathormone, and 25(OH)D levels were also determined before and during treatment. Results were compared between the groups. Data obtained from the groups were analyzed using one-way analysis of variance. The number of pretreatment attacks in groups 1 to 4 was 7±0.12, 6.8±0.2, 7.3±0.4, and 7.2±0.3 for 6 months, respectively (all P>0.05). The number of attacks during treatment was 3±0.25, 1.76±0.37 (P<0.05), 2.14±0.29 (P<0.05), and 1.15±0.15 (P<0.05), respectively. No statistically significant differences in calcium, phosphorus, alkaline phosphatase, or parathormone levels were observed (P>0.05). Vitamin D given in addition to anti-migraine treatment reduced the number of migraine attacks.


Subject(s)
Adolescent , Child , Female , Humans , Male , Amitriptyline/therapeutic use , Analgesics, Non-Narcotic/therapeutic use , Migraine Disorders/drug therapy , Vitamin D/therapeutic use , Analysis of Variance , Alkaline Phosphatase/blood , Chi-Square Distribution , Calcium/blood , Drug Combinations , Non-Randomized Controlled Trials as Topic/statistics & numerical data , Prospective Studies , Parathyroid Hormone/blood , Vitamin D/blood
4.
West Indian med. j ; 62(8): 776-777, Nov. 2013.
Article in English | LILACS | ID: biblio-1045752

ABSTRACT

Rhabdomyolysis is caused by myocyte necrosis, which results in the release of muscular cell contents into the circulation and extracellular fluid. We present a case of rhabdomyolysis due to brucella infection without any complications. Following the treatment for brucella, creatinine kinase level was significantly reduced. Rhabdomyolysis associated with brucella is rare in children.


La rabdomiolisis es causada por necrosis del miocito, que resulta de la liberación de los contenidos de la célula muscular en la circulación y el líquido extracelular. Presentamos un caso de rabdomiolisis debido a infección por brucella sin complicaciones. Tras el tratamiento aplicado por brucella, se redujo significativamente el nivel de creatinina kinasa. La rabdomiólisis asociada a brucella es rara en niños.


Subject(s)
Humans , Male , Adolescent , Rhabdomyolysis/etiology , Brucellosis/complications , Rhabdomyolysis/drug therapy , Rifampin/therapeutic use , Brucellosis/drug therapy , Brucellosis/blood , Doxycycline/therapeutic use , Anti-Bacterial Agents/therapeutic use
5.
Braz. j. med. biol. res ; 46(10): 904-908, 24/set. 2013. tab, graf
Article in English | LILACS | ID: lil-688559

ABSTRACT

Familial Mediterranean fever (FMF) is a periodic autoinflammatory disease characterized by chronic inflammation. This study investigated the relationship between acute-phase reactants and gene mutations in attack-free periods of childhood FMF. Patients diagnosed with FMF were divided into four groups based on genetic features: no mutation, homozygous, heterozygous, and compound heterozygous. These groups were monitored for 2 years, and blood samples were collected every 6 months during attack-free periods. Erythrocyte sedimentation rate, C-reactive protein, fibrinogen, and white blood cell count were measured. A disease severity score was determined for each patient. Mean values for erythrocyte sedimentation rate and fibrinogen were significantly different in the homozygous group. White blood cell count and C-reactive protein were similar between the groups. Disease severity score was higher in patients with the M694V mutation than in individuals without the mutation, as well as in those with other mutation groups. Periodic follow-up of patients with FMF MEFV mutations in subjects with acute-phase reactants may be useful in the prevention of morbidity.


Subject(s)
Adolescent , Child , Child, Preschool , Female , Humans , Infant , Male , Acute-Phase Proteins/analysis , Familial Mediterranean Fever/genetics , Mutation/genetics , Blood Sedimentation , Biomarkers/blood , C-Reactive Protein/analysis , Familial Mediterranean Fever/blood , Fibrinogen/analysis , Heterozygote , Homozygote , Leukocyte Count , Severity of Illness Index
SELECTION OF CITATIONS
SEARCH DETAIL